HIV Status among Tuberculosis Patients Registered in a Tertiary Care Hospital of Army, Kathmandu, Nepal
DOI:
https://doi.org/10.70280/njph(2026)v3i1.86Keywords:
HIV, Nepal, Prevalence, Risk factors, TBAbstract
Background: Tuberculosis (TB) is a huge public health issue in Nepal. TB can coexist with Human immunodeficiency virus (HIV) infection. TB-HIV co-infection identification and prompt treatment is necessary in army personnels because of the propensity to spread early as many live together in dormitories and share similar lifestyles.
Methods: A cross-sectional observational study was conducted in DOTS center of Shree Birendra Hospital (SBH) in 46 patients from January-April, 2023 using non-random purposive sampling. Data was collected with proforma containing preformed questionnaires through face to face interview and observation of treatment reports. Data was entered and analysed in Microsoft Excel. Ethics clearance was taken from the Institutional Review Committee (Registration No 471, December 2022).
Results: The prevalence of HIV among TB patients was 2.2%. The mean age was 44.0 ±17.98 years and majorities of the participants were married males. Extrapulmonary TB constituted 29(63.1%). Majority of participant consumed alcohol (35) and smoked tobacco products (29) and 18 patients had close contact with TB cases. 3(6.5%) cases were relapse case.
Conclusion: This study showed higher prevalence of HIV among tuberculosis patients in military than the normal population. Efforts to identify HIV among TB patients and vice versa is key to reducing this lethal combination so screening for HIV in all TB patients of Nepali Army is advised at a policy level.
References
World Health Organization. Global Tuberculosis Report 2025. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025.
National Tuberculosis Control Centre. Tuberculosis profile factsheet 2026. Bhaktapur: NTCC, Ministry of Health and Population, Government of Nepal; Available from: https://www.ntcc.gov.np/content/71/tuberculosis-profile-factsheet-2026/.
Sharma S, Dhungana GP, Pokhrel BM, Rijal BP. Opportunistic infections in relation to cd4 level among HIV seropositive patients from central Nepal. Nepal Med Coll J. 2010; 12(1): 1-4.
Dhungel B, Dhungel K, Easow J, Singh Y. Opportunistic infection among HIV seropositive cases in Manipal Teaching Hospital, Pokhara, Nepal. Kathmandu Univ. Med. J. 2009;6(3):335-9.
Gao L, Zhou F, Li X, Jin Q. HIV/TB Co-Infection in Mainland China: A Meta-Analysis. PLoS ONE. 2010; 5(5).
National Tuberculosis Control Center. National Tuberculosis Management Guidelines. National Tuberculosis Control Center. 2019.
Kataria VK, Rosha D, Maudar KK. HIV AND TUBERCULOSIS CO-INFECTION IN A REFERRAL CHEST HOSPITAL. Med J Armed Forces India. 2000 Oct;56(4):298-300. doi: 10.1016/S0377-1237(17)30213-7. Epub 2017 Jun 12. PMID: 28790746; PMCID: PMC5532120.
Chanda-Kapata, P., Kapata, N., Klinkenberg, E. et al. The prevalence of HIV among adults with pulmonary TB at a population level in Zambia. BMC Infect Dis 17, 236 (2017). https://doi.org/10.1186/s12879-017-2345-5
Fok A, Numata Y, Schulzer M, FitzGerald MJ. Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2008 May;12(5):480–92.
Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk Factors for Tuberculosis. Pulm Med. 2013 Feb 12;2013:e828939.
Universe 84a. HIV ELISA : Introduction, Principal, Procedure, Results, Interpretation and Clinical Significance. 2012.Available from: https://universe84a.com/collection/elisa/
National Center for AIDS and STD Control. National HIV testing and treatment-Guidelines 2017. National Center for AIDS and STD Control. 2017. Available from: National HIV Testing and Treatment Guidelines 2017
Centers for Disease Control and Prevention. Types of HIV testing. Centers for Disease Control and prevention. June 22, 2022
CDC. Centers for Disease Control and Prevention. Tuberculosis: The Connection between TB and HIV. 2016 June 21. Available from: https://www.cdc.gov/tb/publications/pamphlets/tbandhiv_eng.htm
United Nation. “Global HIV & AIDS Statistics—Fact Sheet,” Joint United Nations Programme on HIV/AIDS, 2023. Available from: https://www.unaids.org/en/resources/fact-sheet.
Jennifer Lloyd et al. “Systematic Review and Meta-Analysis of HIV Prevalence Among Men in Militaries in Low Income and Middle Income Countries,” Sexually Transmitted Infections. August 2014;90(5): 382–387.
Chanda-Kapata P, Kapata N, Klinkenberg E, Grobusch MP, Cobelens F. The prevalence of HIV among adults with pulmonary TB at a population level in Zambia. BMC Infect Dis. 2017 Mar 29;17(1):236. doi: 10.1186/s12879-017-2345-5. PMID: 28356081; PMCID: PMC5372321.
Manjareeka M, Nanda S. Prevalence of HIV infection among tuberculosis patients in Eastern India. Journal of infection and public health. 2013 Oct 1;6(5):358-62.
Tadesse S, Tadesse T. HIV co-infection among tuberculosis patients in Dabat, northwest Ethiopia. J Infect Dis Immun. 2013 Sep 30;5(3):29-32.
Center for Disease Control (US), Centers for Disease Control, Prevention (US). Morbidity and mortality weekly report. US Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control; 2000
World Health Organization. Tuberculosis. Geneva: World Health Organization; 2026 [cited 2026 Jul 02]. Available from: [https://tbksp.who.int/en/node/2777]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Lee Budhathoki, Rajesh Khatri, Rajendra Neupane, Leela Paudel, Lochana Shrestha, Parag Karki
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the Nepal Journal of Public Health (NJPH) are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License. This license allows others to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
Under the following terms:
- Attribution: Appropriate credit must be given, a link to the license must be provided, and any changes made must be indicated. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
For more details about the license, please visit the Creative Commons website.
